Express News | Palatin Technologies Enters Warrant Inducement Agreement With Institutional Investor To Exercise 3,233,277 Shares Issued In November 2022 And October 2023, Raising $6.1M
Palatin Announces Exercise of Warrants for Approximately $6.1 Million Gross Proceeds
Express News | Palatin Technologies Has Initiated Phase 2 Study Of Bremelanotide, A Melanocortin 4 Receptor, Co-administered With A Phosphodiesterase 5 Inhibitor, For Erectile Dysfunction In Patients That Do Not Respond To PDE5i Monotherapy. Topline Data Is Expected By
Express News | Palatin Technologies: Potential Phase 3 Clinical Study in Ed Patients Who Do Not Respond to Pde5I Monotherapy to Start in H1 2025
Express News | Palatin Announces the Initiation of a Phase 2 Clinical Study of Bremelanotide Co-Administered With a Pde5I for the Treatment of Erectile Dysfunction (Ed)
Sector Update: Health Care Stocks Ease Late Afternoon
Palatin Technologies Starts Phase 2 of Obesity Treatment Study
H.C. Wainwright Maintains Palatin Technologies(PTN.US) With Buy Rating, Maintains Target Price $17
Express News | Palatin Technologies: Additional Studies Under Assessment for Multiple Metabolic Conditions
Express News | Palatin Technologies Inc: Topline Data Expected by End of Calendar Year 2024
Express News | Palatin Initiates Phase 2 Clinical Study of Bremelanotide for the Treatment of Obesity
Palatin Technologies (PTN) Upgraded to Buy: What Does It Mean for the Stock?
Analysts Offer Insights on Healthcare Companies: Palatin Technologies (PTN), Prestige Consumer Healthcare (PBH) and CervoMed (CRVO)
Palatin Technologies Inc (PTN) (Q3 2024) Earnings Call Transcript Highlights: Navigating ...
Q3 2024 Palatin Technologies Inc Earnings Call
Earnings Call Summary | Palatin Technologies(PTN.US) Q3 2024 Earnings Conference
Palatin Technologies Shares Are Trading Lower After the Company Reported Worse-than-expected Q3 GAAP EPS Results.
Analysts Are Bullish on These Healthcare Stocks: AEON Biopharma (AEON), Palatin Technologies (PTN)
Palatin Technologies Q3 24 Earnings Conference Call At 11:00 AM ET
Palatin Technologies | 10-Q: Quarterly report